2013年美国心脏病学会/美国心脏协会胆固醇指南发布后的医疗保险药品目录变更 - Suppr | 超能文献

Medicare Formulary Changes After the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline.

作者信息

Dhruva Sanket S, Desai Nihar R, Karaca-Mandic Pinar, Shah Nilay D, Ross Joseph S

出版信息

J Am Coll Cardiol. 2017 Jan 17;69(2):244-246. doi: 10.1016/j.jacc.2016.10.053.

DOI:10.1016/j.jacc.2016.10.053

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Medicare Formulary Changes After the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline.2013年美国心脏病学会/美国心脏协会胆固醇指南发布后的医疗保险药品目录变更

J Am Coll Cardiol. 2017 Jan 17;69(2):244-246. doi: 10.1016/j.jacc.2016.10.053.

2

Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.2013年美国心脏病学会/美国心脏协会（ACC/AHA）胆固醇管理指南发布后两年内，美国一项大型医保计划中他汀类药物的起始使用模式

J Am Heart Assoc. 2017 May 4;6(5):e005205. doi: 10.1161/JAHA.116.005205.

3

What is the role of the clinical laboratory in the new ACC/AHA guidelines for the treatment of blood cholesterol in adults?临床实验室在新的美国心脏病学会/美国心脏协会成人血胆固醇治疗指南中扮演着什么角色？

Am J Clin Pathol. 2014 Jun;141(6):772-3. doi: 10.1309/AJCPED9X7RNMYAEQ.

4

The 2013 American College of Cardiology/American Heart Association guidelines on treating blood cholesterol and assessing cardiovascular risk: a busy practitioner's guide.《2013年美国心脏病学会/美国心脏协会关于治疗血胆固醇和评估心血管风险的指南：忙碌从业者指南》

Endocrinol Metab Clin North Am. 2014 Dec;43(4):869-92. doi: 10.1016/j.ecl.2014.08.006.

5

New Studies Do Not Challenge the American College of Cardiology/American Heart Association Lipid Guidelines.新研究并未对美国心脏病学会/美国心脏协会的血脂指南构成挑战。

Ann Intern Med. 2016 May 17;164(10):683-4. doi: 10.7326/M15-2428. Epub 2016 Feb 9.

6

Recent AHA/ACC cholesterol guidelines: vice or virtue?近期美国心脏协会/美国心脏病学会胆固醇指南：是祸还是福？

Metabolism. 2014 May;63(5):605-6. doi: 10.1016/j.metabol.2013.12.013. Epub 2014 Jan 7.

7

Implementation of the 2013 American College of Cardiology/American Heart Association Blood Cholesterol Guideline Including Data From the Improved Reduction of Outcomes: Vytorin Efficacy International Trial.2013年美国心脏病学会/美国心脏协会血液胆固醇指南的实施，包括来自改善转归：Vytorin疗效国际试验的数据。

Rev Cardiovasc Med. 2015;16(2):125-30. doi: 10.3909/ricm0762.

8

2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol: Primary Prevention.2018年美国心脏协会/美国心脏病学会多学会血胆固醇管理指南：一级预防

JAMA Cardiol. 2019 May 1;4(5):488-489. doi: 10.1001/jamacardio.2019.0777.

9

Clinical pharmacist understanding of the 2013 American College of Cardiology/American Heart Association cholesterol guideline.临床药师对 2013 年美国心脏病学会/美国心脏协会胆固醇指南的理解。

J Clin Lipidol. 2018 Mar-Apr;12(2):367-374.e3. doi: 10.1016/j.jacl.2017.11.010. Epub 2017 Dec 6.

10

Perspective on the 2013 American Heart Association/American College of Cardiology guideline for the use of statins in primary prevention of low-risk individuals.关于2013年美国心脏协会/美国心脏病学会低风险个体一级预防中他汀类药物使用指南的观点

Circ Res. 2014 Feb 28;114(5):758-60. doi: 10.1161/CIRCRESAHA.114.303333.

引用本文的文献

1

Medicare Coverage and Out-of-Pocket Costs of Quadruple Drug Therapy for Heart Failure.医疗保险覆盖范围和心力衰竭四联药物治疗的自付费用。

J Am Coll Cardiol. 2022 Jun 28;79(25):2516-2525. doi: 10.1016/j.jacc.2022.04.031.

2

Real-World Evidence: Promise and Peril For Medical Product Evaluation.真实世界证据：医疗产品评估的希望与风险

P T. 2018 Aug;43(8):464-472.